Lupus nephritis management guidelines compared

被引:80
|
作者
Wilhelmus, Suzanne [1 ]
Bajema, Ingeborg M. [1 ]
Bertsias, George K. [2 ,3 ]
Boumpas, Dimitrios T. [3 ,4 ]
Gordon, Caroline [5 ]
Lightstone, Liz [6 ]
Tesar, Vladimir [7 ]
Jayne, David R. [8 ]
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
[2] Univ Crete, Sch Med, Rheumatol Clin Immunol & Allergy, Iraklion, Greece
[3] FORTH, IMBB, Infect & Immun Div, Iraklion, Greece
[4] Acad Athens, Biomed Res Fdn, Athens, Greece
[5] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Rheumatol Res Grp,Med Sch, Birmingham, W Midlands, England
[6] Imperial Coll London, Dept Med, Sect Renal Med & Vasc Inflammat, London, England
[7] Charles Univ Prague, Sch Med 1, Dept Nephrol, Prague, Czech Republic
[8] Addenbrookes Hosp, Lupus & Vasculitis Unit, Cambridge, England
关键词
guideline; lupus nephritis; management; systemic lupus erythematosus; treatment; MYCOPHENOLATE-MOFETIL; MEMBRANOUS NEPHROPATHY; MAINTENANCE THERAPY; INDUCTION THERAPY; EUROPEAN LEAGUE; RENAL BIOPSY; ERYTHEMATOSUS; AZATHIOPRINE; RITUXIMAB; CYCLOPHOSPHAMIDE;
D O I
10.1093/ndt/gfv102
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
In the past years, many (randomized) trials have been performed comparing the treatment strategies for lupus nephritis. In 2012, these data were incorporated in six different guidelines for treating lupus nephritis. These guidelines are European, American and internationally based, with one separate guideline for children. They offer information on different aspects of the management of lupus nephritis including induction and maintenance treatment of the different histological classes, adjunctive treatment, monitoring of the patient, definitions of response and relapse, indications for (repeat) renal biopsy, and additional challenges such as the presence of vascular complications, the pregnant SLE patient, treatment in children and adolescents and considerations about end-stage renal disease and transplantation. In this review, we summarize the guidelines, determine the common ground between them, highlight the differences and discuss recent literature.
引用
收藏
页码:904 / 913
页数:10
相关论文
共 50 条
  • [31] Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis
    van Tellingen, A.
    Voskuyl, A. E.
    Vervloet, M. G.
    Bijl, M.
    de Sevaux, R. G. L.
    Berger, S. P.
    Derksen, R. H. W. M.
    Berden, J. H. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (04): : 199 - 206
  • [32] Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare
    Ayoub, Isabelle
    Birmingham, Dan
    Rovin, Brad
    Hebert, Lee
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (04)
  • [33] Guidelines for lupus nephritis—more recommendations than data?
    Brad H. Rovin
    Nature Reviews Nephrology, 2012, 8 : 620 - 621
  • [34] Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis
    Boletis, JN
    Ioannidis, JPA
    Boki, KA
    Moutsopoulos, HM
    LANCET, 1999, 354 (9178): : 569 - 570
  • [35] Identification and Management of Lupus Nephritis: An Overview
    Cadet, Myriam Jean
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (01): : 1 - 6
  • [36] Lupus Nephritis: An Exploration of Management Style
    Nandan, Abhishek
    Syed, Huzaefah
    Vagts, Christen
    Kidd, Jason
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Management of lupus nephritis in children.
    Niaudet, P
    ARCHIVES DE PEDIATRIE, 1999, 6 (12): : 1312 - 1321
  • [38] MANAGEMENT OF LUPUS NEPHRITIS - A RATIONAL APPROACH
    FENG, PH
    RHEUMATOLOGY, SEAPAL 1988, 1989, 809 : 207 - 208
  • [39] A SUCCESSFUL MANAGEMENT OF PREGNANCY WITH LUPUS NEPHRITIS
    Kannan, Kalaivani
    Ravishankar, Sharmila
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (66): : 4756 - 4758
  • [40] Intravenous Immunoglobulin in the Management of Lupus Nephritis
    Wenderfer, Scott E.
    Thacker, Trisha
    AUTOIMMUNE DISEASES, 2012, 2012